# Pasithea Therapeutics Corp.: Form 8-K, filed May 4, 2026

- Company: [Pasithea Therapeutics Corp.](/companies/ktta.md) (CIK 1841330)
- Form: 8-K
- Filed: 2026-05-04
- Accepted by EDGAR: May 4, 2026, 17:00 ET
- Period: 2026-05-01
- Accession: 0001213900-26-051681
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1841330/000121390026051681/ea0288864-8k_pasithea.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1841330/000121390026051681/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1841330/000121390026051681/ea0288864-8k_pasithea.htm

Filed May 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-051681. Last ingested by Listed: Nov 14, 2026, 23:46 ET. No prices; not investment advice.
